Publications

The EAU Research Foundation has published the following publications.

Search in Publications

Can zoledronic acid prevent bone metastases in high-risk non-metastatic prostate cancer patients? Efficacy and safety results of the Zometa European Study (ZEUS).

12. Wirth M, Tammela T, Cicalese V, Gomez Veiga F, Delaere K, Miller K, Tubaro A, Schulze M, Debruyne F, Huland H, Patel A, Lecouvet F, Caris C, Witjes W. A prospective, randomized, open-label, multi-national study of the European Association of Urology (EAU) in co-operation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft für Urologische Onkologie (AUO).

Evolution: A European registry evaluating management practices of pharmacologically treated patients with LUTS associated with BPH. Symptomatic improvement, progression and treatment discontinuation results. A comparison between European countries.

A. Tubaro, R. Berges, M. Speakman, A. de La Taille, L. Martínez-Piñeiro, A. Patel, C. Caris, W. Witjes. EAU Research Foundation, Arnhem, The Netherlands.

A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy

P.F.A. Mulders, M. Colombel, A. Heidenreich, L. Martínez-Piñeiro, M. Babjuk, I. Korneyev, C. Surcel, P. Yakovlev, R. Colombo, P. Radziszewski, J.A. Witjes, R. Schipper, W.P.J. Witjes. An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’.

European registry evaluating management practices of general practitioners and urologists and pharmacological treatment outcomes in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Tubaro A, Berges R, Speakman M, de la Taille A, Martínez-Piñeiro L, Patel A, Caris C, Witjes W.

European registry evaluating management practices of general practitioners and urologists and pharmacological treatment outcomes in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Tubaro A, Berges R, Speakman M, de la Taille A, Martínez-Piñeiro L, Patel A, Caris C, Witjes W.

Периоперационная химиотерапия при инвазивном раке мочевого пузыря: современные представления и обоснование необходимости поиска альтернативных методов лечения.

И.А.Корнеев, И.А.Абоян, Б.Я.Алексеев, О.И.Аполихин, Б.К.Комяков, В.Б.Матвеев, M. Colombel, A. Heidenreich, L. Martínez-Piñeiro, M. Babjuk, C. Surcel, P. Yakovlev, R. Colombo, P. Radziszewski, F. Witjes, P. Mulders, R. Schipper, W. Witjes.